Advicenne Reports Full-Year 2019 Financial Results and Confirms Operational Outlook for 2020
March 13, 2020
Nîmes, France, March 13, 2020 – 7:45 a.m. CET – Advicenne (Euronext Paris & Brussels: ADVIC – FR0013296746), a specialty pharmaceutical company focused on the development and commercialization of therapeutic products for rare kidney diseases, today announced its financial results for the year ended December 31, 2019 and confirmed its 2020 operational outlook.